Premium
Nurix Therapeutics Inc (NRIX)
NASDAQ
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted pr... Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies. Its drug candidate from E3 ligase inhibitor portfolio, NX-1607, is an orally available CBL-B inhibitor for immuno-oncology indications. Show more
SAN FRANCISCO, Feb. 04, 2025 (GLOBE NEWSWIRE) -- Nurix Therapeutics, Inc. (Nasdaq: NRIX), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization...
Reported a robust objective response rate of 75.5% from the Phase 1 study of NX-5948 in patients with relapsed/refractory CLL/SLL at the 66th American Society of Hematology Annual Meeting...
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | -0.99 | -4.94752623688 | 20.01 | 20.5 | 18.29 | 722163 | 19.28210134 | CS |
| 4 | 0 | 0 | 19.02 | 20.66 | 17.5 | 700641 | 19.28847197 | CS |
| 12 | -8.09 | -29.8413869421 | 27.11 | 27.53 | 17.5 | 832320 | 20.62346357 | CS |
| 26 | -1.84 | -8.82070949185 | 20.86 | 29.56 | 17.5 | 774776 | 22.6174154 | CS |
| 52 | 10.65 | 127.240143369 | 8.37 | 29.56 | 8.11 | 894305 | 18.85361128 | CS |
| 156 | 0.78 | 4.27631578947 | 18.24 | 29.56 | 4.22 | 603131 | 14.76149462 | CS |
| 260 | -1.23 | -6.07407407407 | 20.25 | 52.38 | 4.22 | 514106 | 18.48716166 | CS |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
